Lv4
660 积分 2023-05-04 加入
CSPG4 and B7-H3 as prognostic biomarkers in chordoma
14天前
已关闭
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
2个月前
已完结
Recent advances in the development of bispecific antibodies
2个月前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
4个月前
已完结
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
4个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
5个月前
已完结
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
7个月前
已完结
Clinical delivery system for intraperitoneal hyperthermic chemotherapy
7个月前
已关闭
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
7个月前
已完结
Bevacizumab and Recurrent Malignant Gliomas: A European Perspective
8个月前
已完结
皖公网安备34019202002308
